7Ragaz J, Olivotto ZA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy : 20-year results of the British Columbia randomized trial. J Natl Cancer Inst,2005 ,97 :116-126.
8Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ : ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol,2006,24 : 3381-3387.
9Jones SE, Holmes FA, OShaughnessy JA,et al. Extended follow- up and analysis by age of the US Oncology Adjuvant Trial 9735 : docetaxel/cyclophosphamide is associated with an overall survival benefit compared to doxorubicin/cyclophosphamide and is well- tolerated in women 65 or older. Breast Cancer Res Treat, 2007, 106 suppl 1 : S5-11.
10Gol~lhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Annals of Oncology, 2007, 18: 1133-1144.
